Active, Not Recruiting
CFI-402257, a Potent and Selective TTK Inhibitor, in Solid Tumors and With Fulvestrant in Breast Cancer
NCT05251714
- Conditions
- Advanced Solid Tumor, Breast Cancer, Breast Diseases, +5 more
- Locations
-
- The Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
- START San Antonio San Antonio, Texas, United States
- START - Mountain Region West Valley City, Utah, United States
- Virginia Cancer Specialist Fairfax, Virginia, United States